PADI4 and acute promyelocytic leukemia: By employing an integrative multiomics approach encompassing mass cytometry, transcriptomics, and proteomics analysis, we systematically characterized the differentiation-associated metabolic shifts in PAD4 inhibitor-treated APL cells at single-cell resolution and reveal key regulatory nodes connecting citrullination signaling with metabolic pathways.